PEX , a phosphate-regulating gene with homology to endopeptidases on the X chromosome, was recently identified as the candidate gene for X-linked hypophosphatemia. In the present study, we cloned mouse and human Pex/PEX cDNAs encoding part of the 5 Ј untranslated region, the protein coding region, and the entire 3 Ј untranslated region, determined the tissue distribution of Pex/PEX mRNA, and characterized the Pex mutation in the murine Hyp homologue of the human disease. Using the reverse transcriptase/polymerase chain reaction (RT/PCR) and ribonuclease protection assays, we found that Pex/PEX mRNA is expressed predominantly in human fetal and adult mouse calvaria and long bone. With RNA from Hyp mouse bone, an RT/PCR product was generated with 5 Ј but not 3 Ј Pex primer pairs and a protected Pex mRNA fragment was detected with 5 Ј but not 3 Ј Pex riboprobes by ribonuclease protection assay. Analysis of the RT/ PCR product derived from Hyp bone RNA revealed an aberrant Pex transcript with retention of intron sequence downstream from nucleotide 1302 of the Pex cDNA. Pex mRNA was not detected on Northern blots of poly (A) ϩ RNA from Hyp bone, while a low-abundance Pex transcript of Ϸ 7 kb was apparent in normal bone. Southern analysis of genomic DNA from Hyp mice revealed the absence of hybridizing bands with cDNA probes from the 3 Ј region of the Pex cDNA. We conclude that Pex/PEX is a low-abundance transcript that is expressed predominantly in bone of mice and humans and that a large deletion in the 3 Ј region of the Pex gene is present in the murine Hyp homologue of X-linked hypophosphatemia. ( J. Clin. Invest . 1997. 99:1200-1209.)
Introduction
X-linked hypophosphatemia (XLH) 1 (MIM #307800) is the most frequently occurring form of inherited rickets in humans with an incidence of 1 in 20,000 individuals (1, 2) . It is a dominant disorder of phosphate homeostasis characterized by rachitic and osteomalacic bone disease, short stature, hypophosphatemia, and renal defects in phosphate reabsorption and vitamin D metabolism (2) . Much of our knowledge of the human disease is derived from studies of the murine Hyp mutation (2) (3) (4) (5) , which maps to a region of the mouse X chromosome that is syntenic to the XLH ( HYP ) locus on the human X chromosome (6) . We demonstrated that Hyp mice have a specific defect in phosphate transport across the renal brush border membrane that is associated with a decrease in high affinity Na ϩ -phosphate cotransport V max (7) and can be ascribed to a decrease in renal abundance of type II Na ϩ -phosphate cotransporter ( Npt2 ) mRNA and immunoreactive protein (8) . We also showed that the regulation of the vitamin D catabolic enzyme, 1,25-dihydroxyvitamin D-24-hydroxylase, is perturbed in Hyp mouse kidney (9) (10) (11) (12) . However, the NPT2 and 24-hydroxylase genes have been ruled out as candidate genes for XLH and Hyp since both genes map to autosomes (13, 14) .
Recently, a candidate gene for XLH was identified by an international consortium using a positional cloning approach (15). The gene was designated PEX to signify a Phosphateregulating gene with homology to Endopeptidases on the X chromosome (15). DNA samples from 150 unrelated individuals with XLH were analyzed; deletions ranging from 1 to 55 kb were identified in four XLH patients and one frameshift and two splice site mutations found in three other individuals (15). More than 20 additional PEX mutations have since been reported (16) (17) (18) , demonstrating molecular heterogeneity for XLH.
The PEX gene contains significant homology to a family of metalloprotease genes which include neutral endopeptidase 24.11 (NEP) and endothelin converting enzyme-1 (ECE-1) (15). These are type II integral membrane glycoproteins, characterized by a short cytoplasmic domain, a transmembrane domain, and a large extracellular domain which retains full catalytic activity. In addition to these similarities, the putative extracellular domain of PEX has a zinc binding motif that is essential for catalytic activity and conserved cysteine residues that are critical for protein conformation in NEP (15).
The mechanism whereby mutations in PEX elicit the XLH phenotype is not clear. It has been demonstrated that NEP is involved in the proteolytic degradation and inactivation of various small peptide mediators (19) whereas ECE-1 plays an important role in the activation of endothelin from an inactive precursor peptide, big endothelin-1 (20) . Based on these findings, one can speculate that PEX is involved in the processing/ degradation of a hormone that is involved in the regulation of renal phosphate handling and the maintenance of phosphate homeostasis.
To understand the physiological role of PEX , a knowledge of its tissue distribution is essential. Although the consortium was unable to detect PEX mRNA expression on Northern
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blots from multiple human and mouse tissues (15), a recent study provided evidence for a low-abundance 6.6-kb Pex transcript in mouse bone and cultured mouse osteoblasts (21) . Of interest was the finding that a Pex transcript was not detected in Hyp bone (21) . The present study was undertaken to clone mouse and human Pex / PEX ( Pex/PEX signifies the mouse [ Pex ] and human [ PEX ] genes, cDNAs, transcripts, or proteins) cDNAs, to determine the distribution of Pex / PEX transcripts in human fetal and murine tissues and to define the nature of the Pex mutation in Hyp mice. These studies provide a basis for understanding Pex / PEX function and the mechanism whereby Pex / PEX mutations perturb phosphate homeostasis, bone mineralization, and growth.
Methods
Human fetal tissues. Tissues from human fetuses (11-22 wk fetal age) were obtained at the time of therapeutic abortion by dilatation and curettage. The samples were flash frozen in a dry ice/acetone bath and stored at Ϫ 70 Њ C. Fetal age was determined by foot length (22) . Protocols for obtaining the fetal tissues were approved by local Institutional Review Boards and informed consent was obtained in all cases.
Mice. Mutant Hyp hemizygote and normal male mice, obtained by breeding C57Bl/6J Hyp / ϩ females with C57Bl/6J ϩ /Y males, were used in the present study. The original breeding pairs were obtained from The Jackson Laboratory (Bar Harbor, ME). Hyp mice were distinguished from normal littermates by their lower body weight, shorter tail, and hypophosphatemia (3). The mice were maintained on Teklad Rodent Diet (diet no. 8604; Harlan Teklad, Madison, WI) containing 1.2% calcium and 1% Pi. Mouse embryos were harvested at day 18. All experiments were conducted in accordance with the guidelines of the Canadian Council on Animal Care.
Isolation of total and poly(A) ϩ RNA. Total RNA was extracted from various human fetal and mouse tissues using TRIzol reagent (Gibco-BRL, Burlington, Ontario). Poly(A) ϩ RNA selection was achieved with oligo(dT 30 ) covalently linked to polystyrene latex beads (Oligotex mRNA kit; Qiagen, Chatsworth, CA), according to the manufacturer's protocol.
Reverse transcriptase (RT)-PCR. Total RNA (5-10 g) from human fetal and mouse tissues was reverse transcribed using random hexamers and SuperScript reverse transcriptase (Gibco-BRL), as recommended by the manufacturer. PCR was initially performed using primers derived from the human PEX sequence (15). Mouse and human Pex / PEX cDNA sequences, corresponding to nucleotides 142-1914 (numbering refers to the mouse and human Pex / PEX cDNA sequences [ Fig. 1 A ] with A of the ATG initiation codon designated as one) were derived by sequencing PCR products obtained with the following primer pairs: ( a ) 5 Ј -CAAGCTAAACAGGAGTACTGCC-3 Ј (F142) and 5 Ј -CCTCTTCCCCTTGACATTTAAG-3 Ј (R1914); ( b ) F142 and 5 Ј -GCCTCGCTGGTTCGGTTTTCATG-3 Ј (R884); ( c ) 5 Ј -AGAAATCAATCAGTAGAAGGCG-3 Ј (F359) and R884. For RT/PCR of ␤ -actin mRNA, the following primer pair was used: 5 Ј -AAC-CGCGAGAAGATGACCCAGATCATGTTT-3 Ј and 5 Ј -AGCAGC-CGTGGCCATCTCTTGCTCGAAGTC-3 Ј . For RT/PCR of Pex transcripts in bone of normal and Hyp mouse, the following primer pairs were used: ( a ) 5 Ј pair: F142 and R884; ( b ) 3 Ј pair: 5 Ј -ATCCGAC-GACTGTCAATGCC-3 Ј (F1598) and R1914.
To characterize the Pex transcript in bone of Hyp mice, 10 g of total RNA isolated from long bone was reverse transcribed as above using an antisense mouse Pex primer: 5 Ј -TCTAGACAGTATCTG-TTCAAAG-3 Ј (R2425). The first cDNA amplification reaction was performed with primers 5 Ј -TTCTGTGTTCATCCGTTTGT-3 Ј (F600) and R2425. A second round of PCR was performed using primers 5Ј-TTGTATGTGTCCCCTGATGA-3Ј (F616) and R2425. Only one round of PCR was necessary to obtain an amplified product with reverse-transcribed RNA from normal mouse bone.
Genomic DNA from normal and Hyp mice was PCR amplified with forward primer 5Ј-GTTCACTTCCAGGAGGTTAAG-3Ј (F1273) and reverse primer 5Ј-ACCACTATTCTGGGTGTTTG-3Ј (RI-1). The sequence of RI-1 was based on the putative intronic sequence identified in the Pex transcript cloned from Hyp mouse bone.
PCR was performed in a DNA Thermal Cycler (480; PerkinElmer Corp., Norwalk, CT) with either Taq polymerase or ELON-GASE (Gibco-BRL) in 1.5 mM MgCl 2 , 0.2 M of each primer, 20 M of each dNTP, as recommended by the supplier. Cycling profiles included an initial denaturating step of 3 min at 94ЊC followed by 35 cycles at 94ЊC for 45 sec, 60ЊC for 2 min, 72ЊC for 1-3 min, and a final extension at 72ЊC for 7 min. For long range PCR, ELONGASE was used with extension times of 10-20 min. ELONGASE was also used for 5Ј-and 3Ј-RACE (see below) and to generate PCR products designated for sequencing. PCR products were fractionated on 1-2% agarose gels, visualized with ethidium bromide and, in some cases, subcloned into a pCR 2.1 plasmid vector (TA Cloning kit; Invitrogen, San Diego, CA) as recommended by the supplier.
Rapid amplification of cDNA ends (5Ј-and 3Ј-RACE). For 5Ј-RACE, mouse poly(A) ϩ RNA (1 g) isolated from bone was reverse transcribed using 200 U of SuperScript with Pex primer R884 (see above). The single-strand cDNA was purified and the 5Ј end extended for 30 min at 37ЊC with 30 U of terminal deoxynucleotidyl transferase (Gibco-BRL) in the presence of 0.1 mM dATP and 1.5 mM CoCl 2 . A first round of PCR was performed using a second Pex primer (5Ј-ATCAGGGGACACATACAAACGG-3Ј; R633) and a hybrid dT 20 adapter primer with a 5Ј extension anchor (5Ј-ACCCTT-CCGAAGCTTGCACT 20 -3Ј). A nested amplification was performed using a third Pex primer (5Ј-CAGCCAAGGATAAACCCCATAG-3Ј; R321) and the anchor primer (5Ј-ACCCTTCCGAAGCTTGCAC-3Ј). Several PCR products were obtained as visualized on 1% agarose gels. Southern blotting of the gel and hybridization, with 32 
P-labeled
Pex primer F142 as a probe, was used to determine the specific band corresponding to the 5Ј-RACE product. The latter, a 450-bp fragment, was subcloned into pCR 2.1 vector and sequenced.
The 5Ј end of human PEX cDNA was obtained by reverse transcribing total RNA (10 g) from human fetal calvaria using random primers and PCR amplification with a forward PEX primer based on the 5Ј mouse Pex cDNA sequence (5Ј-AGAGTCTTGAATATC-AAACG-3Ј; F-minus110) and R321. The 431-bp fragment was subcloned into pCR 2.1 vector and sequenced.
For 3Ј-RACE, mouse and human bone poly(A) ϩ RNA (1 g) were reverse transcribed using the dT 20 adapter primer with the 5Ј extension anchor described above. PCR was performed with the anchor primer and the following Pex primers: first round 5Ј-CTCGCAAGT-ATTTAGCACAGTC-3Ј (F1526); second round F1598. The 900-bp products were subcloned into pCR 2.1 vector and sequenced.
DNA sequencing. Subcloned fragments were sequenced at the Sheldon Biotechnology Centre (McGill University) using Thermo Sequenase DNA polymerase (Amersham, Oakville, Ontario) and an ABI 373 automated sequencing system. Double-stranded DNA sequencing of PCR products was performed by the dideoxynucleotide chain termination reaction using the dsDNA Cycle Sequencing System (Gibco-BRL) according to the manufacturer's protocol. Three to four clones of each subcloned fragment were sequenced from both strands using Pex/PEX primers and T7 and M13 reverse primers. Sequence analysis and alignments were performed using the computer program PC Gene version 6.85.
Ribonuclease protection analysis. The ribonuclease protection assay was performed essentially as described by Gilman (23) . A 317-bp cDNA fragment corresponding to nucleotides 567 to 884 of the human PEX cDNA sequence and a 246-bp cDNA fragment corresponding to nucleotides 1668-1914 of the mouse Pex cDNA sequence were subcloned in pBluescript II KS(-) (Stratagene, La Jolla, CA) and used as templates to generate the 5Ј-PEX and 3Ј-Pex riboprobes, respectively. The plasmids were linearized with BamHI and used to synthesize, in vitro, antisense RNA probes with T3 RNA polymerase and [␣- The sizes of the 5Ј-PEX and 3Ј-Pex riboprobes were 405 bp and 326 bp, respectively, and that of their RNase T1-protected fragments 320 bp and 245 bp, respectively. As internal standards, a HindIII-KpnI ␤-actin cDNA fragment, subcloned in pGEM3 (Promega, Madison, WI) and linearized with CvnI, and an XbaI-ApaI GAPDH cDNA fragment subcloned in pBluescript II and linearized with StyI, were used for the synthesis of 32 P-labeled antisense riboprobes with T7 RNA polymerase. The sizes of the riboprobes were 160 bp for ␤-actin and 190 bp for GAPDH and that of the protected fragments 137 bp and 164 bp, respectively. Total RNA (10-20 g) extracted from various human fetal and mouse tissues was hybridized with the labeled riboprobes (5 ϫ 10 5 cpm) at 50ЊC for 18 h and treated with 2 g/ml RNase T1 at 30ЊC for 1 h. The protected fragments were precipitated, heat denatured and electrophoresed on a 6% denaturing polyacrylamide gel. The gel was dried and exposed to a PhosphorImager TM screen (Fuji PhosphorImager Bas 2000, Tokyo, Japan) for quantitation and to Kodak Biomax MR1 film for photography. Approximately 30 min exposure was necessary to visualize the ␤-actin and GAPDH signals whereas a 3-4 d exposure was required for the Pex/ PEX signal. Pex/PEX phosphorimage signals were related to those of ␤-actin or GAPDH under conditions where we previously demonstrated a linear relationship between the quantity of RNA used and the resulting phosphorimage signal.
Northern analysis. Poly(A) ϩ RNA, prepared from 250 g of total RNA, was heat denatured and size fractionated on a 1.5% agarose gel containing 18% formaldehyde as previously described (11) and capillary blotted to a Zeta-Probe nylon membrane (BioRad, Mississauga, Ontario). The membrane was ultraviolet irradiated for 2 min and baked under vacuum at 80ЊC for 30 min. A 1.8-kb mouse Pex cDNA fragment, corresponding to nucleotides 142-1914, was labeled by random priming with [␣- 32 P]dCTP and used as probe. Prehybridization (5 min at 49ЊC) and hybridization (24 h at 49ЊC) were performed in 50% formamide, 0.12 M Na 2 HPO 4 , pH 7.2, 0.25 M NaCl, and 7% SDS. Blots were washed to high stringency (final wash in 0.1 ϫ SSC/0.1% SDS, 60ЊC, 15 min) and exposed to Kodak Biomax MR1 film at Ϫ80ЊC. After stripping, the membranes were rehybridized with a 32 P-labeled 1.3-kb ␤-actin cDNA probe, as described above. Southern blotting. Mouse genomic DNA was prepared from liver of normal and Hyp male mice, as previously described (24) . 10 g of the genomic DNA was digested separately with EcoRI, BamHI, HindIII, PstI, SstI, or a combination thereof, fractionated on 0.7% agarose gels and capillary transferred to nylon-supported nitrocellulose membranes (Optitran BA-(S)85; Schleicher & Schuell, Keene, NH). The membranes were baked under vacuum at 80ЊC for 2 h. P]dCTP and a DNA labeling kit (RadPrime; Gibco-BRL). Membranes were hybridized (18 h at 42ЊC) in 40% formamide, 4 ϫ SSC, 5 ϫ Denhardt's, 100 g/ml denatured herring sperm DNA, 10% dextran sulfate, 1% SDS, and 20 mM Tris, pH 7.6. The membranes were washed to high stringency (final wash in 0.1 ϫ SSC/ 0.1% SDS at 65ЊC) and exposed to a Kodak Biomax MR1 film at Ϫ80ЊC for 48 h.
Results
Cloning of murine and human Pex/PEX cDNAs. We cloned and sequenced 2.7-kb mouse and human Pex/PEX cDNA fragments (Fig. 1 A) . The 5Ј untranslated region (UTR), protein coding region, and 3Ј UTR of the mouse and human cDNAs exhibit 77, 91, and 73% identity, respectively. Polyadenylation signals (AATAAA) were identified at nucleotide 2495 of the mouse Pex cDNA and nucleotide 2484 of the human PEX cDNA. The complete amino acid sequence of the human PEX protein is depicted in Fig. 1 B and includes NH 2 -terminal amino acid residues 1-3 and COOH-terminal amino acid residues 642-749 that were not reported previously (15). Within the additional 108 COOH-terminal amino acids are three cysteine residues that are conserved in NEP (19) and ECE-1 (20) . Alignment of the translated murine and human Pex/PEX cDNAs demonstrates 96% identity at the amino acid level (Fig. 1 B) . Both contain a zinc binding motif in the putative extracellular domain (Fig. 1 B) . Four amino acid differences with the published human sequence (15) were noted ( Fig. 1 B: Ala 363, Trp 403, Arg 567, and Gly 641) and each of these residues was conserved in the mouse Pex protein (Fig. 1 B) (21) .
Pex/PEX mRNA expression in human fetal and murine tissues. We screened a panel of human fetal tissues for PEX mRNA expression by RT/PCR. An amplified PEX fragment, corresponding to nucleotides 359-884 of the human PEX cDNA, was obtained by RT/PCR of RNA from calvaria, long bone, lung, ovary, and muscle (Table I) . Although RT/PCR is not strictly quantitative, the data suggest that PEX mRNA is more abundant in calvaria and lung than in ovary and muscle (Fig. 2 A) . We could not detect an RT/PCR product with RNA from kidney, liver, adrenal, heart, colon, testis, brain, duodenum, pancreas, spleen, thymus, and placenta (Table I and Fig.  2 A) . In contrast, a ␤-actin RT/PCR product was generated from all tissues examined (Fig. 2 A and data not shown) . Water blanks and reactions performed in the absence of reverse transcriptase were all negative ( Fig. 2 A and data not shown) . The identity of the PEX PCR products from calvaria, lung, ovary, and muscle was confirmed by digestion with PstI; in each case, the expected 212-bp and 314-bp fragments were obtained (Fig. 2 B) . In addition, we determined that the sequences of the 526-bp amplified fragments from lung and cal- 
Tissues from fetuses ranging from 11 to 22 wk fetal age were used to prepare total RNA. The RNA was reverse transcribed and PCR amplified using PEX primers F359 and R884 as described in Methods. An aliquot of each PCR reaction was electrophoresed on 1.5% agarose gels and visualized with ethidium bromide. PCR reactions were scored for the presence (ϩ) or abscence (Ϫ) of an amplified PEX product. In some age groups, more than one fetus was examined, as indicated by superscript numbers; the latter depict the number of samples in each group.
varia were identical to the published PEX cDNA sequence (15). PEX expression data in human fetal tissues, as a function of fetal age, are summarized in Table I . All fetal calvarial (12-19 wk) and long bone (12-16 wk) samples tested were positive for PEX mRNA expression. While lung samples from fetuses of 11 and 12 wk fetal age were devoid of detectable PEX transcripts, PEX mRNA was expressed in all lung samples from 14-19-wk fetuses. RNA samples from skeletal muscle of 14-to 19-wk fetuses were also positive for PEX mRNA. In addition, we detected a PEX PCR product with reverse-transcribed RNA from an ovary of a 19-wk fetus but found no evidence for PEX mRNA expression in testes from 14-and 16-wk fetuses. Significantly, all renal samples examined were devoid of PEX mRNA.
PEX mRNA expression in human fetal tissues was also examined by ribonuclease protection assay (Fig. 3) . As expected from RT/PCR data, a protected PEX fragment of the expected size was observed in calvaria, ovary, lung, and muscle but not in kidney and liver, whereas ␤-actin protected fragments were detected in all tissues (Fig. 3) . By normalizing the protected PEX mRNA signal to that of ␤-actin, we found that the relative abundance of PEX mRNA expression in calvaria was approximately sevenfold greater than that in lung, ovary, and muscle (n ϭ 3). Similar data were obtained when GAPDH abundance was used to normalize the data (n ϭ 3). These results, however, do not take into account tissue-specific differences in ␤-actin and GAPDH mRNA expression. The exposure time necessary to generate the PEX signal was ‫ف‬ 150 times longer than that for the ␤-actin and GAPDH signals. These findings suggest that the level of PEX mRNA expression in human fetal tissues is at least two orders of magnitude lower than that of ␤-actin or GAPDH.
We detected Pex transcripts in whole mouse embryo, adult mouse calvaria, long bone and lung, and, to a lesser extent, in adult mouse brain, testis, and muscle by RT/PCR of total RNA (Fig. 4) . Pex transcripts were not detected in kidney, liver, or heart (Fig. 4) . Pex mRNA expression in adult mouse bone and lung was also confirmed by ribonuclease protection assay (see Fig. 7, A and B) .
Effect of the Hyp mutation on Pex mRNA expression. Primer pairs from the 5Ј (F142 and R884) and 3Ј (F1598 and R1914) regions of the mouse Pex cDNA (Fig. 5 A) were used to amplify reverse transcribed RNA derived from bone of adult normal and Hyp mice. With RNA from normal mouse bone, RT/PCR products of the anticipated size were generated with both 5Ј and 3Ј primer pairs (Fig. 6) . In contrast, with RNA isolated from Hyp bone, an RT/PCR product of the expected size was obtained with the 5Ј but not the 3Ј primer pair (Fig. 6 ). These data suggest that there may be a deletion in the 3Ј region of the Pex transcript in Hyp mice. We used a ribonuclease Figure 2 . RT/PCR of human fetal tissue RNA. (A) Total RNA from human fetal bone (calvaria), lung, kidney, liver, adrenal, heart, colon, testis, ovary, and muscle was reverse transcribed and PCR amplified using PEX (F359 and R884, top) and ␤-actin primers (bottom) as described in Methods. An aliquot of each PCR reaction was electrophoresed on 1.5% agarose gels and visualized with ethidium bromide. A water blank and an incubation performed in the absence of reverse transcriptase are shown. (B) PEX RT/PCR products derived from fetal bone (calvaria), lung, ovary, and muscle RNA were incubated in the absence (Ϫ) and presence (ϩ) of PstI, electrophoresed, and visualized as described in A. Figure 3 . Ribonuclease protection assay of human fetal tissue RNA. Total RNA (10 g) from human fetal calvaria, ovary, kidney, liver, lung, and muscle was hybridized with 32 Plabeled 5Ј PEX (Fig. 5  A) and ␤-actin riboprobes and treated with RNase T1 as described in Methods. The protected PEX (320-bp) and ␤-actin (137-bp) fragments were precipitated, electrophoresed on polyacryamide gels, and visualized by autoradiography as described in Methods. A protected PEX fragment was never detected in RNA from kidney and liver. Figure 4 . RT/PCR of mouse tissue RNA. Total RNA from whole mouse embryo, adult mouse calvaria, bone, lung, kidney, liver, brain, heart, testis, and muscle, was reverse transcribed and PCR amplified using Pex/PEX primers (F142 and R884). An aliquot of each PCR reaction was electrophoresed and visualized as described in the legend for Fig. 2 . protection assay to test this hypothesis. With a 5Ј-PEX riboprobe (Fig. 5 A) , protected Pex fragments were detected with RNA isolated from lung and bone, but not liver, of both normal and Hyp mice (Fig. 7 A) . However, with a 3Ј-Pex riboprobe (Fig. 5 A) , a protected Pex fragment was detected with RNA from bone and lung of normal mice but not with RNA from the corresponding tissues of Hyp mice (Fig. 7 B) . Protected ␤-actin fragments were detected in RNA samples isolated from all tissues examined (Fig. 7, A and B) . These results are consistent with the notion that there is a deletion in the 3Ј region of the Pex transcript in mice harboring the Hyp mutation. The ribonuclease protection assay also confirms that Pex mRNA is expressed in bone and lung, but not in liver and muscle, of normal adult mice (Fig. 7, A and B) .
To define the boundaries of the putative deletion in the Pex transcript of Hyp mice, RNA isolated from bone of normal and mutant mice was reverse transcribed with R2425 and P-labeled 5Ј PEX and ␤-actin riboprobes and treated with RNase T1 as described in Methods. Using the 5Ј PEX riboprobe, protected Pex fragments (320-bp) were detected in RNA from both normal and Hyp bone and lung. (B) Total RNA (20 g) from bone, lung, liver, and muscle of normal and Hyp mice was hybridized with 32 P-labeled 3Ј Pex and ␤-actin riboprobes and treated as described in (A). Using the 3Ј Pex riboprobe, protected Pex fragments (245-bp) were only detected in RNA from normal bone and lung. There was no evidence for a protected Pex fragment in RNA from either liver or muscle of normal and Hyp mice. Protected ␤-actin fragments (137-bp) were detected in RNA from all tissues examined (A and B).
PCR amplified with F616 and R2425 (Fig. 5 B) . The amplified product from Hyp bone was Ϸ 1 kb shorter than that from normal bone. The sequence of the RT/PCR product from Hyp bone was identical to that of normal Pex cDNA between nucleotides 616 and 1302 (Fig. 5 B) . However, the next 48 bases in the amplified product from Hyp bone were not found in mouse Pex cDNA (Fig. 5 B) . The first six bases in this region, GTAAGT, were typical of a splice donor site sequence, suggesting that nucleotide 1302 is at the junction of an exon/intron boundary in the Pex gene and that the 48 bases comprise part of an intron that is retained in the mutant Pex transcript (Fig.  5 B) . Indeed, using primer F1273 and a reverse primer from within the putative intron (RI-1, Fig. 5 B) , we were able to amplify, from genomic DNA of both normal and Hyp mice, a PCR product with a sequence identical to that present in the aberrant Hyp transcript (Fig. 5 B) . In addition, using primers F616 and RI-1, we were able to RT/PCR a cDNA fragment of the expected size with RNA from Hyp, but not normal, bone (data not shown). Immediately following the 48 bases of the intron are two bases, GA, followed by the reverse primer, R2425, sequence (Fig. 5 B) . Taken together, the data suggest that the Pex transcript in Hyp mice is characterized by an interruption in the normal Pex cDNA sequence at nucleotide 1302 and the retention of at least 48 bases from the adjacent intron.
Northern analysis of poly (A)
ϩ RNA was performed to compare the sizes of the Pex transcripts in normal and Hyp mouse bone and lung. A very low-abundance Pex transcript of Ϸ 7 kb was detected in bone and lung of normal adult mice and in normal mouse embryo (Fig. 8) . However, we could not detect a Pex transcript in bone and lung of Hyp mice (Fig. 8) . Neither mouse strain expressed Pex mRNA in kidney (Fig. 8) , in agreement with RT/PCR data (Fig. 4) . A 2.2-kb transcript was evident in all lanes upon rehybridization of the Northern blot with a ␤-actin cDNA probe, confirming the integrity of the mRNA, particularly in those samples devoid of Pex transcript (Fig. 8) .
Southern analysis of genomic DNA from normal and Hyp mice was performed to determine whether the deletion in the Pex transcript was the result of a major rearrangement in the Pex gene. The Pex cDNA probes tested (a-h, Fig. 5 A) fell into three distinct groups with respect to their hybridization patterns with normal and Hyp DNA. With probes a, b, and d, similar hybridization patterns were obtained with normal and Hyp DNA (e.g., Fig. 9 A) . With probes c and e, some but not all bands were absent with DNA from Hyp mice (e.g., Fig. 9 B) . However, with probes f, g, and h from the 3Ј region of the Pex cDNA, no hybridization signal was detected with DNA from Hyp mice (e.g., Fig. 9 C) . Based on the position of the probes tested and the Southern blots generated, we conclude that there is a 3Ј deletion in the Pex gene of Hyp mice and suggest that the deletion occurs around nucleotide 1668 of the Pex cDNA. Based on the sizes of missing bands with probes c, e, f, g, and h, we estimate that the Pex deletion in Hyp mice is between 18 and 33 kb.
Discussion
The HYP consortium recently identified a candidate gene, PEX, for XLH by positional cloning (15). While more than 25 mutations in the PEX gene have been identified in patients with XLH (15-18), the genetic basis for the murine Hyp homologue of the human disease is not known. Moreover, no information about PEX tissue distribution was provided by the consortium and only a partial PEX cDNA was isolated (15). In the present study, we cloned murine and human Pex/PEX cDNAs comprising part of the 5Ј UTR, the complete protein coding region and the entire 3Ј UTR, we examined the distribution of Pex/PEX mRNA in human fetal and murine tissues and defined the nature of the PEX mutation in mice harboring the X-linked Hyp mutation. We show that Pex is a very lowabundance transcript of Ϸ 7 kb that is preferentially expressed in bone and that the Hyp mutation results from a large deletion in the 3Ј region of the Pex gene.
The preferential expression of Pex/PEX in bone is of interest and consistent with the presence of bone disease in XLH patients and Hyp mice. Previous studies have shown that histomorphometric parameters of bone formation are not normalized after transplantation of bone cells from Hyp mice into the gluteal muscle of normal mice or phosphate-supplemented Hyp mice (25) (26) (27) . These data suggest that the hypophosphatemic environment, arising from the renal phosphate leak, is not sufficient for the bone disease in Hyp mice. Additional evidence for an intrinsic bone defect in Hyp mice was derived from the demonstration that gluconeogenesis is abnormally elevated and steady state intracellular pH is significantly decreased in cultured osteoblasts derived from Hyp mice when compared with normal osteoblasts (28, 29) . While further work is necessary to identify the precise function of Pex/PEX in bone and the mechanism whereby loss of Pex/PEX function mediates the bone abnormalities in XLH and Hyp, our data clearly show that Pex/PEX is expressed early in bone development.
Studies in the Hyp mouse demonstrated that the renal defect in phosphate transport in not intrinsic to the kidney but rather depends on a circulating factor for its expression (30, 31) . The present demonstration that Pex/PEX is not expressed in kidney is consistent with these findings and suggests that Pex/PEX expression at extrarenal site(s) is involved in the processing/inactivation of an endocrine factor that is involved in the regulation of renal phosphate handling. Additional studies are required to identify the Pex/PEX substrate and to assess the contribution of Pex/PEX expression at sites other than bone (e.g., lung) in the regulation of renal phosphate reabsorption. Moreover, the relationship between the Pex/PEX substrate and phosphotonin, the putative phosphaturic factor produced by tumors from patients with oncogenic hypophosphatemic osteomalacia (tumor-induced osteomalacia), remains to be established (32, 33) .
In the present study, we provide evidence for a deletion in the 3Ј region of the Pex gene in Hyp mice using a variety of approaches. RT/PCR (Fig. 6 ) and ribonuclease protection assays (Fig. 7, A and B) clearly demonstrate the presence of 5Ј but not 3Ј sequences in the Pex transcript derived from Hyp bone. Analysis of the RT/PCR product demonstrates the absence of Pex cDNA sequence downstream from nucleotide 1302 of the normal Pex cDNA (Fig. 5 B) . Finally, we show by Southern analysis that genomic DNA from Hyp mice does not hybridize with probes from the 3Ј region of the Pex cDNA (Fig. 9 C) .
Based on the data from Southern analyses, we estimate that the deletion in the 3Ј region of the Pex gene in Hyp mice is between 18 and 33 kb. Our findings are consistent with those described in an abstract by Strom et al. (34) in which a deletion of the 3Ј end of the Pex gene was reported in Hyp mice. However, our findings are at odds with a recent report by Du et al. (21) in which no mutation was detected in the Pex cDNA generated by RT/PCR of RNA from Hyp mouse bone. While Du et al. suggested that the Hyp mutation may reside in either an untranslated region or in the promoter of the Pex gene, one cannot rule out the possibility that their results are due to contamination with normal Pex cDNA, given the sensitivity of PCR assays (21) .
We demonstrate that at least 48 bases of intron sequence are retained in the Pex transcript derived from Hyp mouse bone and that the intron sequence is found downstream from nucleotide 1302 of the normal Pex cDNA. Evidence supporting this conclusion was derived from sequence analysis of PCR products generated from genomic DNA of normal or Hyp mice, using primers that flank the exon/intron junction at nucleotide 1302 (F1273 and RI-1, a reverse primer from the putative intron region [ Fig. 5 B] ). However, we could not PCR amplify the intron that is retained in the Pex transcript of Hyp mice or estimate the size of the deletion in the Pex gene by long range PCR of normal and Hyp genomic DNA, using primer F1273 in combination with several reverse primers from the 3Ј region of the Pex cDNA. Because we were able to PCR amplify an 11-kb fragment of the Npt2 gene (24) using the same genomic DNA templates, we conclude that the intron in question and the deletion are very large and/or that all the reverse primers tested span an intron/exon junction. Both are likely possibilities given that the Pex gene is very large and Figure 9 . Southern blot analysis of genomic DNA from normal and Hyp mice. DNA (10 g) was digested to completion with EcoRI, HindIII, or SstI, electrophoresed on 0.7% agarose gels, transferred to a supported nitrocellulose membrane, and hybridized with is comprised of many small exons, as is the case for the homologous gene encoding NEP (35) .
The precise mechanism for the retained intron sequence in the Pex transcript of Hyp mice is unclear. A recent survey of splice mutations found that only 6% are associated with intron retention in the aberrant transcript (36) . In most instances, intron retention can be ascribed to mutations in the 5Ј donor splice site (36) (37) (38) , which is clearly not the mechanism operating in Hyp. However, there are at least two reports in which intron retention is associated with deletions in intron sequences that result in the activation of cryptic donor and acceptor splice sites (39, 40) . This latter mechanism may indeed explain the present findings in the Hyp mouse.
The sequence downstream from the 48 bases of the retained intron in the aberrant Pex transcript of Hyp mice consists of GA followed by the sequence of the reverse primer (R2425) used to generate the PCR product. This may represent the true Pex transcription product in Hyp mice. Alternatively, the mutant RT/PCR product may be the result of an amplification reaction in which the reverse primer annealed to an unrelated but partially complementary sequence in the retained intron. Since the structure of the Pex gene is not known, we cannot distinguish between these possibilities at present. In any case, the aberrant Pex transcript in Hyp mice is likely to be highly unstable and this may explain why we were unable to detect the aberrant transcript by Northern analysis of poly (A) ϩ RNA from Hyp mouse bone and lung (Fig. 8) . The latter findings are consistent with the results of Du et al. who also failed to detect a Pex transcript on Northern blots of total RNA isolated from Hyp mouse bone (21) .
In summary, we have shown that Pex/PEX is a very lowabundance transcript of ‫ف‬ 7 kb that is preferentially expressed in bone of mice and humans. We have also presented evidence for a large deletion in the 3Ј region of the Pex gene in mice harboring the X-linked Hyp mutation. Our data are consistent with the absence of functional Pex protein in Hyp mice and support the hypothesis that loss of Pex function is responsible for the mutant Hyp phenotype.
